Insulins

Eli Lilly & Co (NYSE: LLY), in an effort to make it easier for patients to access affordable insulin and navigate the complex healthcare system, announced on Wednesday a 70% reduction in the list price of its most commonly prescribed insulin products. The company also announced an...

Insulet Corporation (NASDAQ: PODD) presented data from the pivotal trial extension phase of the Omnipod 5 Automated Insulin Delivery System.  Omnipod 5 is a tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends. Data showed...

Investors appear to be pleased with Eli Lilly and Co (NYSE: LLY)'s business after the company updated the investment community with short- and longer-term guidance. Eli Lilly's stock gained more than 5 percent on Thursday and was trading higher by another 1.50 percent at $72.45 ahead of Friday's...